Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis

American Journal of Pathology

Volumn 174, Issue 6, 2009, Pages 2357-2366

  Madson, Justin G ^a   Lynch, David T ^a   Svoboda, Jessica ^a   Ophardt, Rebecca ^a   Yanagida, Jodi ^a   Putta, Sumanth K ^a   Bowles, Andrew ^a   Trempus, Carol S ^b   Tennant, Raymond W ^b   Hansen, Laura A ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 25A; CHECKPOINT KINASE 1; CHECKPOINT KINASE RAD3; DIMETHYL SULFOXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA TELANGIECTASIA; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; EPIDERMIS HYPERPLASIA; GENE DELETION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SKIN TUMOR; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION;

EID: 67049162195     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080638     Document Type: Article

References (40)

1. Madson JG, Lynch DT, Tinkum KL, Putta SK, Hansen LA: Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiation. Am J Pathol 2006, 169:1402-1414 (Pubitemid 351194373)
2. Coffer PJ, Burgering BM, Peppelenbosch MP, Bos JL, Kruijer W: UV activation of receptor tyrosine kinase activity. Oncogene 1995, 11:561-569
3. Huang RP, Wu JX, Fan Y, Adamson ED: UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol 1996, 133:211-220 (Pubitemid 26107108)
4. Rosette C, Karin M: Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996, 274:1194-1197 (Pubitemid 26389285)
5. Han CY, Lim SC, Choi HS, Kang KW: Induction of ErbB2 by ultraviolet A irradiation: potential role in malignant transformation of keratinocytes. Cancer Sci 2008, 99:502-509 (Pubitemid 351228566)
6. Bol D, Kiguchi K, Beltran L, Rupp T, Moats S, Gimenez-Conti I, Jorcano J, DiGiovanni J: Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter. Mol Carcinog 1998, 21:2-12 (Pubitemid 28097945)
7. Xie W, Wu X, Chow LT, Chin E, Paterson AJ, Kudlow JE: Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles. Cell Growth Differ 1998, 9:313-325 (Pubitemid 28345885)
8. Krahn G, Leiter U, Kaskel P, Udart M, Utikal J, Bezold G, Peter RU: Coexpression patterns of EGFR. HER2, HER3 and HER4 in non-melanoma skin cancer Eur J Cancer 2001, 37:251-259
9. Maubec E, Duvillard P, Velasco V, Crickx B, Avril MF: Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res 2005, 25:1205-1210 (Pubitemid 40546791)
10. El Abaseri TB, Putta S, Hansen LA: Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor. Carcinogenesis 2006, 27:225-231 (Pubitemid 43159873)
11. Jean C, Hernandez-Pigeon H, Blanc A, Charveron M, Laurent G: Epidermal growth factor receptor pathway mitigates UVA-induced G2/M arrest in keratinocyte cells. J Invest Dermatol 2007, 127:2418-2424 (Pubitemid 47619744)
12. Peus D, Vasa RA, Meves A, Beyerle A, Pittelkow MR: UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol 2000, 72:135-140
13. Wan YS, Wang ZQ, Shao Y, Voorhees JJ, Fisher GJ: Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int J Oncol 2001, 18:461-466
14. El Abaseri TB, Fuhrman J, Trempus C, Shendrik I, Tennant RW, Hansen LA: Chemoprevention of UV light-induced skin tumorigenesis by inhibition of the epidermal growth factor receptor. Cancer Res 2005, 65:3958-3965 (Pubitemid 40616379)
15. Shtivelman E, Sussman J, Stokoe D: A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr Biol 2002, 12:919-924 (Pubitemid 34689227)
16. Bortul R, Tazzari PL, Billi AM, Tabellini G, Mantovani I, Cappellini A, Grafone T, Martinelli G, Conte R, Martelli AM: Deguelin. A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. Br J Haematol 2005, 129:677-686 (Pubitemid 40825830)
17. Box AH, Demetrick DJ: Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis 2004, 25:2325-2335 (Pubitemid 39625172)
18. Cimprich KA, Cortez D: ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 2008, 9:616-627 (Pubitemid 352032926)
19. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J: The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410:842-847 (Pubitemid 32303786)
20. Lee CH, Chung JH: The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation. J Biol Chem 2001, 276:30537-30541 (Pubitemid 37385143)
21. Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Bartek J, Lukas J: Rapid destruction of human Cdc25A in response to DNA damage. Science 2000, 288:1425-1429 (Pubitemid 30366329)
22. Xiao Z, Chen Z, Gunasekera AH, Sowin TJ, Rosenberg SH, Fesik S, Zhang H: Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem 2003, 278:21767-21773 (Pubitemid 36792580)
23. Lichti U, Anders J, Yuspa SH: Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nature Protocols 2008, 3:799-810 (Pubitemid 351639024)
24. Hassepass I, Voit R, Hoffmann I: Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint. J Biol Chem 2003, 278:29824-29829 (Pubitemid 36962370)
25. Leu M, Bellmunt E, Schwander M, Farinas I, Brenner HR, Muller U: Erbb2 regulates neuromuscular synapse formation and is essential for muscle spindle development. Development 2003, 130:2291-2301 (Pubitemid 36722382)
26. Vindelov LL: Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei Virchows Arch B Cell Pathol 1977, 24:227-242
27. Trempus CS, Mahler JF, Ananthaswamy HN, Loughlin SM, French JE, Tennant RW: Photocarcinogenesis and susceptibility to UV radiation in the v-Ha-ras transgenic Tg.AC mouse. J Invest Dermatol 1998, 111:445-451 (Pubitemid 28400092)
28. De Potter IY, Poumay Y, Squillace KA, Pittelkow MR: Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation. Exp Cell Res 2001, 271:315-328 (Pubitemid 33141213)
29. Hirose Y, Katayama M, Mirzoeva OK, Berger MS, Pieper RO: Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence. Cancer Res 2005, 65:4861-4869 (Pubitemid 40740825)
30. King FW, Skeen J, Hay N, Shtivelman E: Inhibition of Chk1 by activated PKB/Akt. Cell Cycle 2004, 3:634-637 (Pubitemid 40278209)
31. Clarke CA, Clarke PR: DNA-dependent phosphorylation of Chk1 and claspin in a human cell-free system. Biochem J 2005, 388:705-712 (Pubitemid 40839948)
32. Puc J, Parsons R: PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cells. Cell Cycle 2005, 4:927-929 (Pubitemid 41359759)
33. Puc J, Keniry M, Li HS, Pandita TK, Choudhury AD, Memeo L, Mansukhani M, Murty VV, Gaciong Z, Meek SE, Piwnica-Worms H, Hibshoosh H, Parsons R: Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 2005, 7:193-204 (Pubitemid 40248344)
34. Tuna M, Chavez-Reyes A, Tari AM: HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene 2005, 24:1648-1652 (Pubitemid 40396095)
35. Xia W, Bisi J, Strum J, Liu L, Carrick K, Graham KM, Treece AL, Hardwicke MA, Dush M, Liao Q, Westlund RE, Zhao S, Bacus S, Spector NL: Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers. Cancer Res 2006, 66:1640-1647 (Pubitemid 43259948)
36. He YY, Huang JL, Chignell CF: Delayed and sustained activation of extracellular signal-regulated kinase in human keratinocytes by UVA: implications in carcinogenesis. J Biol Chem 2004, 279:53867-53874 (Pubitemid 40051896)
37. Wang HQ, Quan T, He T, Franke TF, Voorhees JJ, Fisher GJ: Epidermal growth factor receptor-dependent. NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes J Biol Chem 2003, 278:45737-45745 (Pubitemid 37432717)
38. Xu Y, Shao Y, Voorhees JJ, Fisher GJ: Oxidative inhibition of receptor-type protein-tyrosine phosphatase kappa by ultraviolet irradiation activates epidermal growth factor receptor in human keratinocytes. J Biol Chem 2006, 281:27389-27397 (Pubitemid 44401766)
39. Citri A, Yarden Y: EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 2006, 7:505-516 (Pubitemid 44036456)
40. Maklad A, Nicolai JR, Bichsel KJ, Evenson JE, Lee T-C, Threadgill DW, Hansen LA: The EGFR is required for proper innervation to the skin. J Invest Dermatol 2009, 129:690-698